VIVEbiotech joins the Pañuelo Challenge on International Childhood Cancer Day
Over 60% of the lentiviral vectors we manufacture support therapies targeting different types of cancer, strengthening our commitment to patients and their families.
On February 15, International Childhood Cancer Day was commemorated—an important date dedicated to raising awareness and supporting children and teenagers facing this disease, as well as their families.
To mark this day, VIVEbiotech joined the Pañuelo Challenge, a initiative led by the Aladina Foundation to raise visibility around childhood cancer. Our team took part by wearing the symbolic scarf as a gesture of support and empathy for those who confront this reality with admirable strength.
At VIVEbiotech, we work on the development and manufacturing of lentiviral vectors used by biotechnology companies, research institutions, and pharmaceutical organizations involved in the field of advanced therapies.
Currently, over 60% of the vectors we produce are used in programs aimed at treating different types of cancer, which makes this cause especially meaningful to us.
We would like to acknowledge the invaluable work carried out by the Aladina Foundation, whose dedication to supporting children, teenagers, and families affected by cancer is essential to improving their well‑being and quality of life.
💛 At VIVEbiotech, we continue working every day to help improve the quality of life of many people.